← All trials
NCT05320380
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2022
- Primary completion
- Sep 1, 2023
- Completion date
- Sep 1, 2023
- First posted
- Apr 11, 2022
- Last posted
- Oct 24, 2022
- Enrollment
- 38
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LLS PedAL Initiative, LLCLead sponsor
- National Cancer Institute (NCI)Collaborator
- National Cancer Institute (NCI)Collaborator
- National Cancer Institute (NCI)Overall official - principal investigator
- National Cancer Institute (NCI)Reponsible party - principal investigator
- ImmunogenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.